---
title: Combination therapy with hypomethylating agents and venetoclax versus intensive
  induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A
  multicenter cohort study
date: '2024-05-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38751104/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240516181522&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...